230 related articles for article (PubMed ID: 25735321)
1. Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors.
Ibrahim NY; Sroor MY; Darwish DO
Asian Pac J Cancer Prev; 2015; 16(3):1007-10. PubMed ID: 25735321
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
4. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
5. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
6. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
7. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours.
Carmichael AR; Bendall S; Lockerbie L; Prescott R; Bates T
Eur J Surg Oncol; 2002 Jun; 28(4):388-91. PubMed ID: 12099647
[TBL] [Abstract][Full Text] [Related]
8. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer.
Takahashi H; Watanabe K; Takahashi M; Taguchi K; Sasaki F; Todo S
Breast Cancer; 2005; 12(3):196-202. PubMed ID: 16110289
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer.
Heaton KM; Peoples GE; Singletary SE; Feig BW; Ross MI; Ames FC; Buchholz TA; Strom EA; McNeese MD; Hunt KK
Ann Surg Oncol; 1999; 6(1):102-8. PubMed ID: 10030422
[TBL] [Abstract][Full Text] [Related]
10. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
[TBL] [Abstract][Full Text] [Related]
11. Bilateral breast carcinoma: clinical characteristics and its impact on survival.
Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL
Breast J; 2010; 16(6):625-32. PubMed ID: 21070440
[TBL] [Abstract][Full Text] [Related]
12. Synchronous and metachronous bilateral breast cancer: A long-term experience.
Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
[TBL] [Abstract][Full Text] [Related]
13. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.
Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K
Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461
[TBL] [Abstract][Full Text] [Related]
14. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features in bilateral breast cancer.
Baykara M; Ozturk SC; Buyukberber S; Helvaci K; Ozdemir N; Alkis N; Berk V; Koca D; Coskun U; Oksuzoglu B; Uncu D; Arpaci E; Ustaalioglu BO; Demirci U; Kucukoner M; Dogu GG; Alici S; Akman T; Ozkan M; Aslan UY; Durnali AG; Benekli M
Asian Pac J Cancer Prev; 2012; 13(9):4571-5. PubMed ID: 23167382
[TBL] [Abstract][Full Text] [Related]
16. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.
Díaz R; Munárriz B; Santaballa A; Palomar L; Montalar J
Med Oncol; 2012 Mar; 29(1):16-24. PubMed ID: 21193967
[TBL] [Abstract][Full Text] [Related]
18. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
19. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Lee J; Park S; Kim S; Kim J; Ryu J; Park HS; Kim SI; Park BW
Yonsei Med J; 2015 Sep; 56(5):1213-20. PubMed ID: 26256962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
